Home - Products - Others - Other Targets - 3,4,5-Trimethoxy-trans-cinnamic acid

3,4,5-Trimethoxy-trans-cinnamic acid

CAS No. 20329-98-0

3,4,5-Trimethoxy-trans-cinnamic acid ( O-Methylsinapic acid; 3,4,5-Trimethoxyphenylacrylic acid )

Catalog No. M23909 CAS No. 20329-98-0

3,4,5-Trimethoxy-trans-cinnamic acid is a natural product from the roots and rhizomes of Notopterygium incisum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 38 In Stock
100MG 59 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3,4,5-Trimethoxy-trans-cinnamic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3,4,5-Trimethoxy-trans-cinnamic acid is a natural product from the roots and rhizomes of Notopterygium incisum.
  • Description
    3,4,5-Trimethoxy-trans-cinnamic acid is a natural product from the roots and rhizomes of Notopterygium incisum.
  • Synonyms
    O-Methylsinapic acid; 3,4,5-Trimethoxyphenylacrylic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20329-98-0
  • Formula Weight
    238.2
  • Molecular Formula
    C12H14O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc(/C=C/C(O)=O)cc(OC)c1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Joseph S S , Lynham J A , Molenaar P , et al. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the β1-adrenoceptor in human atrium and recombinant receptors[J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2003, 368(6):496-503.
molnova catalog
related products
  • Ataquimast

    Ataquimast is used in curing advanced receptor-positive breast cancer.

  • N4-Benzoyl-2′-deoxyc...

    N4-Benzoyl-2′-deoxycytidine is a chemical compound.

  • Uprosertib

    Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.